NCT02890381 · Interventional trial
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Overall registry status Terminated
Phase 1
Conditions Respiratory Syncytial Virus Infections
Delaware Valley sites
- Philadelphia IMPAACT Unit CRS · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory